Arthur Bobin
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
-
- Peptidase Inhibition and Analysis
- CAR-T cell therapy research
- Cancer Treatment and Pharmacology
Papers in
- Hematology 30
- Multiple Myeloma Research and Treatments 27
- Oncology 14
- Peptidase Inhibition and Analysis 7
- Cancer Treatment and Pharmacology 4
- Co-authors
- Xavier P. Leleu (10 shared papers)Stéphanie Guidez (5 shared papers)Anthony Lévy (5 shared papers)Cécile Tomowiak (5 shared papers)Geraldine G. Durand (1 shared paper)Mathieu Puyade (1 shared paper)Vincent Javaugue (1 shared paper)Évelyne Liuu (1 shared paper)
- Journals
- Cancer Medicine (3 papers)Cancers (3 papers)British Journal of Haematology (2 papers)Blood Cancer Journal (2 papers)Haematologica (2 papers)
- Partner nations
- FranceRussiaUnited States
In The Last Decade
Arthur Bobin
28 papers receiving 250 citations
Peers
Comparison fields: 5 of 29
- Hematology 190
- Oncology 98
- Genetics 21
- Molecular Biology 100
- Immunology 16
Countries citing papers authored by Arthur Bobin
This map shows the geographic impact of Arthur Bobin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arthur Bobin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arthur Bobin more than expected).
Fields of papers citing papers by Arthur Bobin
This network shows the impact of papers produced by Arthur Bobin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arthur Bobin. The network helps show where Arthur Bobin may publish in the future.
Co-authors
The 25 scholars most cited alongside Arthur Bobin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 65 | |
| 2 | 2020 | 25 | |
| 3 | 2019 | 19 | |
| 4 | 2023 | 15 | |
| 5 | 2022 | 13 | |
| 6 | 2018 | 13 | |
| 7 | 2023 | 12 | |
| 8 | 2024 | 10 | |
| 9 | 2024 | 10 | |
| 10 | 2019 | 8 | |
| 11 | 2021 | 7 | |
| 12 | 2018 | 7 | |
| 13 | 2020 | 7 | |
| 14 | 2023 | 6 | |
| 15 | 2020 | 5 | |
| 16 | 2019 | 5 | |
| 17 | 2023 | 5 | |
| 18 | 2025 | 4 | |
| 19 | 2022 | 3 | |
| 20 | 2020 | 3 |
About Arthur Bobin
Arthur Bobin is a scholar working on Hematology, Oncology, Genetics, Molecular Biology and Pathology and Forensic Medicine, having authored 35 papers that have together received 256 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (27 papers), Protein Degradation and Inhibitors (14 papers), Peptidase Inhibition and Analysis (7 papers), Cancer Treatment and Pharmacology (4 papers), Lymphoma Diagnosis and Treatment (4 papers), Chronic Lymphocytic Leukemia Research (4 papers), Cancer therapeutics and mechanisms (4 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). The work is most often cited by research in Hematology (190 citations), Oncology (98 citations), Genetics (21 citations), Molecular Biology (100 citations) and Immunology (16 citations). Arthur Bobin has collaborated with scholars based in France, Russia and United States. Frequent co-authors include Xavier P. Leleu, Stéphanie Guidez, Anthony Lévy, Cécile Tomowiak, Geraldine G. Durand, Mathieu Puyade, Vincent Javaugue, Évelyne Liuu, É. Frouin and Marie Masson Regnault. Their work appears in journals such as Cancer Medicine, Cancers, British Journal of Haematology, Blood Cancer Journal and Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.